Patients Treated With Risperidone Long Acting Injection Had A Significantly Longer Time To Relapse Compared To Quetiapine In Clinical Study
May 15th 2008Drug InformationSchizophrenia
Nearly half of patients with schizophrenia fail to remain on their medication treatment, which can result in a relapse of symptoms (1,2). Today, data from a new international study showed that patients treated with risperidone long-acting injection (RLAI) had a significantly longer time to relapse (3) compared to patients treated with an oral atypical medication, quetiapine.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
